GH1 and breast cancer: More recently, chemically-induced mammary tumors established in wild-type rats and GH supplemented spontaneous dwarf rats responded to doxorubicin treatment with regression of tumors in the dwarf animals when GH supplementation was stopped, whereas poor doxorubicin response was observed in GH-sufficient wild-type animals (65).